Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
On the Origins of MAOI Misconceptions: Reaffirming their Role in Melancholic Depression
1
x
$
30.00
VOL 2 No. 8 Full Issue - August 2000
1
x
$
20.00
Probable Olanzapine-Related Idiopathic Intracranial Hypertension in an Adolescent with First-Episode Psychosis
1
x
$
30.00
The Addition of Amphetamine to Potentially Sedating Medication Regimens: An Exploratory Investigation of the Impact upon Reaction Time and Sustained Attention
1
x
$
30.00
Takotsubo Cardiomyopathy Related to Duloxetine-Atomoxetine Combination in an Adolescent with ADHD and Comorbid GAD
1
x
$
30.00
Criteria for Defining Symptomatic and Sustained Remission in Bipolar I Disorder: a Post-Hoc Analysis of a 26-Week Aripiprazole Study (Study CN138-010)
1
x
$
30.00
Phebe Tucker, MD: Can Physiologic Assessment and Side Effects Tease Out Differences in PTSD Trials? A Double-Blind Comparison of Citalopram, Sertraline, and Placebo
1
x
$
30.00
Donald S. Robinson, MD: Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials
1
x
$
30.00
Ryan M. Carnahan, PharmD: The Relationship of an Anticholinergic Rating Scale With Serum Anticholinergic Activity in Elderly Nursing Home Residents
1
x
$
30.00
View Cart
Checkout
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Boadie W. Dunlop, MD: Disturbed Glucose Metabolism Among Patients Taking Olanzapine and Typical Antipsychotics
$
30.00
Add to cart
Details
Page load link
Go to Top
